Replies to post #179354 on Biotech Values

[DewDiligence]

MDT-COV addendum: Various people have posited that the political agitation in the wake of the (failed) PFE-AZN deal will create a rush to close tax-inversion deals before the US imposes further restrictions on such dealmaking (#msg-101714163).

[DewDiligence]

MDT reconfirms tax-inversion merger with COV:

http://finance.yahoo.com/news/medtronic-announces-updated-financing-plans-131802285.html

Medtronic, Inc…today announced that it intends to use approximately $16 billion in external financing to complete the acquisition of Covidien plc, rather than using cash from its foreign subsidiaries as previously planned. All terms and conditions of the definitive agreement reached between the two companies in June remain unchanged.

[DewDiligence]

MDT-COV tax-inversion merger has closed:

http://finance.yahoo.com/news/covidien-announces-effectiveness-medtronic-transaction-215500740.html

[DewDiligence]

MDT acquires HTWR for $58/sh in cash—a 93% premium to Friday’s close:

http://finance.yahoo.com/news/medtronic-expand-heart-failure-portfolio-104701788.html

Having re-domiciled in Ireland via the merger with Covidien, MDT can now be more aggressive in M&A.